Attention Shareholders: Pomerantz Law Firm Launches Investigation into Fibrogen Inc. (FGEN) for Investor Claims
Attention Shareholders: Pomerantz Law Firm Launches Investigation into Fibrogen Inc. (FGEN) for Investor Claims Description: New York, July 01, 2023 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of FibroGen, Inc. (“FibroGen” or the “Company”) (NASDAQ: FGEN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext….